Actively Recruiting
Evaluation of Quality of Life, Safety, and Therapy Adherence in Schizophrenia or Bipolar Disorder Patients Using Quetiapine Alone or in Combination with Other Antipsychotics
Led by Bosnalijek D.D · Updated on 2026-10-15
500
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This observational study focuses on patients diagnosed with schizophrenia or bipolar affective disorder. It aims to evaluate the quality of life, safety, and therapy adherence in patients treated with quetiapine either alone or combined with other antipsychotic drugs such as aripiprazole or haloperidol. Participants include newly diagnosed patients as well as those already receiving antipsychotic therapy who require additional quetiapine treatment. Participants receive treatment as prescribed by their physicians, either quetiapine monotherapy or in combination with aripiprazole or haloperidol. The study divides participants into groups based on their diagnosis and treatment approach. The study does not assign treatments but observes patients on these therapies during routine care. Participants attend four visits baseline, 4 months, 8 months, and 12 months after enrollment. During the study, researchers assess quality of life using the World Health Organization Quality of Life questionnaire WHOQOL-BREF, monitor safety by recording any adverse drug events, and evaluate therapy adherence using the Medication Adherence Rating Scale MARS. All assessments occur over a 12-month period. Participants health and treatment responses are tracked at scheduled visits to gather data on the outcomes and safety of quetiapine-based therapies.
CONDITIONS
Brief Title
Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder
Research Team
H
Halima Karakaš
U
Una Glamoclija, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here